Aarti Drugs fundamental analysis

AARTIDRUGS

334.35

4.75 (-1.40%)
Last updated on 17 Mar, 2026 | 14:37 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aarti Drugs Fundamentals

P/E Ratio

15.25

P/B Ratio

2.05

Div. Yield

0.3

Sector P/E

59.21

Sector P/B

2.64

Sec. Div. Yield

0.59

Aarti Drugs Fundamentals is currently trading with a P/E Ratio of 15.25, compared to the sector average of 59.21. Its P/B Ratio stands at 2.05, while the sector’s is 2.64. In terms of returns, the stock offers a Dividend Yield of 0.3%, which is than the sector’s 0.59%.

Aarti Drugs Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Moderate

  • quality_check
    Quality

    Average

  • quality_check
    Management

    Good

On its scorecard, Aarti Drugs reflects: Price – Attractive, Growth – Moderate, Quality – Average, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost